Community-acquired pneumonia caused by Kluyvera intermedia: A rare case report

Li Xu1, XiaoLong Zhu1, Yi Liu1,2,3

  • 1Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.

PubMed
Abstract

Insights

Kluyvera intermedia, a rare bacterium, caused pneumonia in a patient despite initial antibiotic treatment. Prompt identification and targeted therapy led to recovery, highlighting the importance of recognizing this opportunistic pathogen.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases

Background:

  • Kluyvera intermedia is a rare Gram-negative bacillus.
  • It is an opportunistic pathogen found in environmental sources.
  • Underrecognition in clinical practice is common due to resemblance to other pathogens.

Observation:

  • A 55-year-old male with hypertension presented with pneumonia symptoms.
  • Initial empirical treatment with Cefotaxime Sodium and Levofloxacin was ineffective.
  • Pulmonary lesions enlarged on follow-up CT scans.

Findings:

  • MRI-guided lung biopsy and fluid culture identified Kluyvera intermedia as the causative agent.
  • The patient received targeted treatment with Ceftizoxime sodium and Levonidazole Sodium Chloride Injection.
  • Significant clinical improvement was observed, leading to discharge after 22 days.

Implications:

  • Reporting more Kluyvera intermedia cases is crucial for understanding its clinical profile.
  • Enhanced recognition aids in developing effective treatment strategies.
  • This case underscores the need for accurate identification of rare pathogens for optimal patient management.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
190
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
269
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
123
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
189
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.7K